PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
5.20
+0.46 (9.70%)
At close: Aug 14, 2026, 4:00 PM EDT
5.27
+0.07 (1.35%)
After-hours: Aug 14, 2026, 7:34 PM EDT
PAVmed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.11 | 0.07 | 3 | 2.45 | 0.38 | 0.5 | |
Revenue Growth | -89.02% | -97.63% | 22.14% | 550.40% | -24.60% | - |
Cost of Revenue | 0.36 | 0.22 | 4.84 | 6.42 | 3.61 | 0.59 |
Gross Profit | -0.25 | -0.15 | -1.85 | -3.97 | -3.24 | -0.09 |
Selling, General & Admin | 20.09 | 17.17 | 36.15 | 48.53 | 60.73 | 34.32 |
Research & Development | 6.37 | 4.49 | 5.93 | 14.28 | 25.34 | 19.85 |
Amortization of Goodwill & Intangibles | - | - | 0.56 | 2.02 | 1.78 | 0.15 |
Operating Expenses | 26.46 | 21.66 | 42.64 | 64.83 | 87.85 | 54.31 |
Operating Income | -26.7 | -21.81 | -44.49 | -68.8 | -91.09 | -54.39 |
Interest Expense | -0.02 | -0.02 | -0.05 | -0.59 | -1.28 | - |
Interest & Investment Income | 0.04 | 0.03 | 0.25 | 0.51 | 0.17 | - |
Other Non Operating Income (Expenses) | 16.42 | 14.19 | 3.96 | -7.6 | -4.33 | 1.68 |
EBT Excluding Unusual Items | -10.26 | -7.61 | -40.32 | -76.48 | -96.53 | -52.71 |
Gain (Loss) on Sale of Investments | -2.5 | 8.48 | 0.53 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 72.29 | 1 | - | - |
Other Unusual Items | -3.67 | -3.35 | -4.07 | -3.78 | -6.71 | -3.42 |
Pretax Income | -16.43 | -2.47 | 28.43 | -79.26 | -103.24 | -56.13 |
Earnings From Continuing Operations | -16.43 | -2.47 | 28.43 | -79.26 | -103.24 | -56.13 |
Minority Interest in Earnings | 4.34 | 2.87 | 11.36 | 15.09 | 14.26 | 5.78 |
Net Income | -12.09 | 0.4 | 39.79 | -64.18 | -88.98 | -50.35 |
Preferred Dividends & Other Adjustments | -1.63 | 4.18 | 7.83 | 2.1 | 0.28 | 0.28 |
Net Income to Common | -10.46 | -3.77 | 31.97 | -66.27 | -89.26 | -50.63 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2 | 1 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 2 | 1 | 2 | 0 | 0 | 0 |
Shares Change | -18.99% | -69.15% | 801.63% | 21.78% | 14.91% | 63.42% |
EPS (Basic) | -4.41 | -5.63 | 99.15 | -274.92 | -450.95 | -293.92 |
EPS (Diluted) | -9.86 | -5.63 | 14.90 | -274.92 | -450.95 | -293.92 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -7.78 | -5.24 | -33.61 | -52.28 | -72.53 | -42.06 |
Free Cash Flow Per Share | -3.28 | -7.81 | -15.46 | -216.88 | -366.39 | -244.17 |
Gross Margin | -220.54% | -207.04% | -61.60% | -161.83% | - | -17.00% |
Operating Margin | -23841.96% | -30712.68% | -1485.38% | -2805.67% | -24161.01% | -10878.60% |
Profit Margin | -9341.96% | -5315.49% | 1067.31% | -2702.69% | -23677.45% | -10126.00% |
Free Cash Flow Margin | -6948.21% | -7376.06% | -1122.17% | -2132.06% | -19237.40% | -8412.00% |
EBITDA | -26.62 | -21.7 | -43.29 | -65.86 | -88.63 | -54.17 |
D&A For EBITDA | 0.08 | 0.11 | 1.2 | 2.93 | 2.46 | 0.23 |
EBIT | -26.7 | -21.81 | -44.49 | -68.8 | -91.09 | -54.39 |